Mereo BioPharma

Mereo BioPharma is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for rare diseases and tumors. They have a diverse portfolio of product candidates in clinical development, with a particular emphasis on rare diseases. Mereo collaborates with a variety of partners to leverage their expertise and resources in bringing these potential treatments to patients. The company has a strong commitment to supporting patient communities and promoting awareness of rare diseases.

Mereo's pipeline includes two rare disease product candidates: setrusumab for the treatment of Osteogenesis Imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). They also have two oncology product candidates in clinical development: Etigilimab (anti-TIGIT) for the treatment of solid tumors and Navicixizumab for the treatment of late-line ovarian cancer. Mereo's mission is to unlock the potential of therapies that are not being progressed by larger pharmaceutical companies, ultimately improving the lives of patients with rare diseases and cancers.

Mereo BioPharma welcomes and considers applications to join its team. If you are interested in working in a collaboratively driven environment and building a career with Mereo, send an updated CV and covering letter to jointheteam@mereobiopharma.com. There is no mention of job flexibility on the website.

Mereo BioPharma is a clinical-stage biopharmaceutical company focused on developing innovative treatments for rare diseases, with a mission to improve the lives of patients who have limited therapeutic options. They are committed to identifying and developing therapies with the greatest unrealized, long-term potential, harnessing the power of science, with their knowledge of the rare diseases they seek to treat and deep relationships with all their stakeholders, to create new possibilities for patients.

Mereo BioPharma fosters a collaborative and inclusive culture driven by a deep passion for helping patients with rare diseases. The company emphasizes efficiency, agility, and innovation, encouraging employees to explore new frontiers and respond quickly to challenges and opportunities. They prioritize the value of collaboration with partners, patient communities, and healthcare professionals, recognizing the importance of diverse perspectives and experiences in advancing their mission.

Mereo BioPharma is committed to fostering an inclusive and collaborative workplace where all employees feel valued and respected. They believe that diversity of thought, experience, and background is essential for innovation and success. Their commitment to diversity, equity and inclusion is reflected in their efforts to attract, retain, and develop a diverse workforce, and they welcome applications from all qualified individuals, regardless of gender, race, ethnicity, sexual orientation, gender identity, religion, disability, age, or other protected characteristics.